Hochschulschrift
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
- Weitere Titel
-
Evaluierung der Kombination von onkolytischem Vaccinia Virus und ionisierender Strahlung in vorklinischen Gliomamodellen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Würzburg, Universität Würzburg, Dissertation, 2012
- Schlagwort
-
Gliom
Vaccinia-Virus
Strahlentherapie
Kombinationstherapie
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2012
- Urheber
- Beteiligte Personen und Organisationen
-
Szalay, Aladár
- URN
-
urn:nbn:de:bvb:20-opus-85309
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Buckel, Lisa
- Szalay, Aladár
- Universität Würzburg
Entstanden
- 2012
Ähnliche Objekte (12)
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Oncolytic vaccinia therapy of squamous cell carcinoma
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Oncolytic vaccinia therapy of squamous cell carcinoma
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Evaluating the combination of oncolytic vaccinia virus and ionizing radiation in therapy of preclinical glioma models
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Oncolytic vaccinia therapy of squamous cell carcinoma
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors